Hims & Hers Health, Inc. · NYSE:HIMS

Hims & Hers Health — Investor Presentation (March 2022)

22 slides from Hims & Hers Health's investor presentation, March 2022

  1. Slide 1: Investor Presentation March 2022

    Investor Presentation March 2022 Hims & Hers Health, Inc. 2022

  2. Slide 2: Disclaimer

    Disclaimer This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements can be identified by the use of forward-looking terminolog

  3. Slide 3: Numerous industries have been disrupted over the course of the last decade

    Numerous industries have been disrupted over the course of the last decade 1994 2006 2009 2012 2013 Retail / Commerce Radio / Music Payments Financial Delivery Technology 2017 1997 2012 Healthcare TV / Video 2008 2009 Transportation Hotels Transportation various societal & technological changes, cou

  4. Slide 4: The U.S. healthcare industry is one of the last trillion dollar industries to be disrupted

    The U.S. healthcare industry is one of the last trillion dollar industries to be disrupted Healthcare3 Retail1 Transportation2 Financial Services2 $4 tn With 330mm people’s $5 tn $2 tn $1.5 tn health at risk, improving the status quo is arguably the most impactful opportunity of our lifetime 1. Ibis

  5. Slide 5: High prices, poor accessibility, and lack of convenience drive high levels of U.S. healthcare friction

    High prices, poor accessibility, Expensive Inaccessible Inconvenient and lack of convenience drive high levels of U.S. healthcare 24 50% 1in4 consumer friction today days of U.S. families can’t ER visits are the result of average time to schedule afford their deductible1 inaccessibility to a first-t

  6. Slide 6: The frictionless experience modern consumers expect, making health and wellness more accessible

    The frictionless experience modern consumers expect, making health and wellness more accessible than ever... 6

  7. Slide 7: Powered by a digitally native, fully verticalized end-to-end experience

    Brand Strong Consumer Brand Trusted Provider Network Technology ...powered by a digitally Clinically Focused EMR native, fully verticalized Personalized Platform end-to-end experience Seamless Experience Digital Prescriptions End-to-end Fulfillment 7

  8. Slide 8: This new front door to health and wellness addresses many friction points

    This new front door to health Affordable Accessible Convenient and wellness addresses many friction points, and 24/7 <1 is just the beginning day Transparent pricing by access nationwide so average time from paying only for treatment everyone can get care, request to provider program vs. traditional

  9. Slide 9: Our team is led by a visionary founder, with support from a veteran leadership team

    Our team is led by a visionary founder, with support from a veteran leadership team that has scaled several leading distruptive companies Andrew Dudum Yemi Okupe Melissa Baird Soleil Boughton Mike Chi Amee Parekh Chief Executive Officer Chief Financial Officer Chief Operations Officer Chief Legal Of

  10. Slide 10: Omnichannel presence is critical to driving higher brand awareness and consumer trust

    Omnichannel presence is a critical part of driving higher brand awareness and consumer trust 2021 2021 +7,000 Locations 2021 ~250 Locations 2022 Online retailer +1,400 Locations 2022 2020 2021 +7,800 Locations 2022 +250 Locations +1,800 Locations 2021 +600 Locations Hims & Hers Amazon store 2021 202

  11. Slide 11: We've seen rapid uptick in adoption across our platform

    We’ve seen rapid uptick in adoption across our platform 5.2mm 5mm+ 21mm+ H&H telehealth Cumulative patient consultations since touchpoints1 launch 2.8mm 1.2mm H&H telehealth 431k consultations since launch ’18 ’19 ’20 ’21 Source: Company internal data Note: All numbers as of December 2021 1. Include

  12. Slide 12: Strong adoption, growth and a trusted brand backed by scalable operational capabilities

    Strong adoption, growth and a trusted brand backed by scalable operational capabilities unlocks our seamless experience and future offerings Columbus Columbus, OH OH 300k sq. ft. Secure regulation standard drug Phoenix storage cage AZ Full automation packaging machinery Phoenix, AZ 25k sq. ft. Compo

  13. Slide 13: We focus on stigmatized conditions that enable deep and long-lasting customer relationships

    High Frequency Engagement We focus on stigmatized conditions that enable us to have deep and long-lasting customer relationships Preferred Trusted Private Digital Brand Experience 13

  14. Slide 14: We are excited by natural areas of expansion into new conditions

    We are excited by natural areas of expansion into new conditions Existing Recently Launched Future Opportunities Anxiety & Primary Hair Loss ED Depression Dermatology Care Sleep Fertility Diabetes Cholesterol Spend $3bn1 $4bn2 $14bn3 $44bn4 $280bn1 $15bn5 $15bn6 $70bn7 $21bn1 Chronic Generic Medicat

  15. Slide 15: Differentiated business model, unique strategy

    differentiated business model unique strategy 15

  16. Slide 16: Significant historical revenue growth + gross margin profile translates to attractive gross profit generation

    Significant historical revenue growth + gross margin profile translates to attractive gross profit generation Year-over-Year Growth % % Gross Margin —— 209% 80% 83% 29% 54% 74% 75% $272 $204 Annual revenue Annual gross profit ($ millions) ($ millions) 117 % CAGR 197% CAGR $149 $109 $83 $45 $27 $8 FY

  17. Slide 17: The majority of revenue across our platform is recurring subscription revenue

    The majority of revenue across our platform is recurring subscription revenue 92% 84% online online (Rx) (subscription) 5% 5% wholesale wholesale 3% 11% online (non- subscription) online (non-Rx) Prescription vs Subscription vs non-prescription non-subscription medication Note: For 12 months ended D

  18. Slide 18: Expanding customer base has driven both new and repeat revenue

    Expanding customer base has driven both new and repeat revenue $247 609 New Revenue1 67 % Repeat Customer ’19-’21 CAGR Revenue2 Subscriptions 66 % ($ millions) (000s) ’19-’21 CAGR 81 % ’19-’21 CAGR $141 312 $82 190 134 $27 EOY 2018 EOY 2019 EOY 2020 EOY 2021 FY 2018 FY 2019 FY 2020 FY 2021 Represent

  19. Slide 19: Strong and improving unit economics provide the ability to invest in platform expansion

    Strong and improving unit economics provide the ability to invest in platform expansion Q1’19 Cohort >1 over 1 year VS. <6 under 6 month Q1’21 Cohort payback payback $32 $20 $8 ($12) ($20) Q1 ’19 Q2 ’19 Q3 ’19 Q4 ’19 Q1 ’21 Q2 ’21 Q3 ’21 Q4 ’21 Cumulative Online Gross Profit1 Paid Marketing Expense2

  20. Slide 20: Strong 2022 outlook

    Strong 2022 outlook1 ($ millions) 2019A 2020A 2021A 2022E1 Revenue $83 $149 $272 $365 - $380 YoY % Growth 209% 80% 83% 34% - 40% Adjusted EBITDA2 ($66) ($8) ($30) ($30) - ($20) Margin % of Revenue (80%) (5%) (11%) (8%) - (5%) Financial guidance provided as of Hims & Health Health, Inc. 4Q21 earnings

  21. Slide 21: Non-GAAP Financial Measures

    Non-GAAP Financial Measures In addition to our financial results determined in accordance with U.S. GAAP, we present Adjusted EBITDA (as defined below) and Adjusted EBITDA margin, each non-GAAP financial measures. We use Adjusted EBITDA and Adjusted EBITDA margin to evaluate our ongoing operations a

  22. Slide 22: Reconciliation of Non-GAAP financial measures

    Reconciliation of Non-GAAP financial measures ($ millions, unaudited) 2019A 2020A 2021A Revenue $82.6 $148.8 $271.9 Net Loss ($72.1) ($18.1) ($107.7) Net Loss margin % of Revenue (87%) (12%) (40%) Depreciation and amortization $0.3 $1.1 $4.1 (Benefit) provision for income taxes $0.1 $0.1 ($3.1) Inte

Hims & Hers Health — Investor Presentation (March 2022) on 6ix